10.88
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
How Ardent Health uses joint ventures to grow - Private Equity Stakeholder Project PESP
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation - ACCESS Newswire
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation | NYSE:ARDT | Press Release - stockhouse.com
Ardent Health Adjusts 2025 Non-GAAP EBITDA and EBITDAR Following SEC Review - Kalkine Media
Ardent Health revises 2025 Adjusted EBITDA to $447.3M, Adjusted EBITDAR to $611.6M after removing $97.7M of non‑GAAP adjustments - TradingView
Is Ardent Health (ARDT) Cheap As UT Tyler Expansion Lifts Its Long Term Outlook? - simplywall.st
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine - Business Wire
Ardent Health (NYSE: ARDT) ex-officer plans $398K stock sale - Stock Titan
Former Ardent Health (NYSE: ARDT) leader lines up new share sale after August trades - Stock Titan
Did You Lose Money Investing in Ardent Health, Inc.? If so, Conta - The National Law Review
Ardent Health (NYSE: ARDT) ex-exec lines up six-figure stock sale - Stock Titan
Ardent Health’s BSA Health System partners with Cardiology Center of Amarillo to expand heart care access - Bitget
Ardent Health (NYSE: ARDT) ex-exec lines up 2026 sale of stock grants - Stock Titan
Sei Investments Co. Lowers Stock Holdings in Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation | NYSE:ARDT | Press Release - Stockhouse
ARDT Q2 2026 Earnings: EPS Misses Estimates by 35.06% as Stock DeclinesFinal Results - vinanet.vn
Why Ardent Health (ARDT) Is Down 5.5% After Cutting 2026 Guidance And Fueling Options JittersAnd What's Next - simplywall.st
Wedge Capital Management L L P NC Acquires 222,447 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Implied Volatility Surging for Ardent Health Stock Options - TradingView
Ardent Health Services Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript - AOL.com
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and "180-Day Cliff" Reserves (PR Newswire) - Aktiellt
A next-generation heart pump is tested during high-risk stenting - Stock Titan
Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 13.84% Potential Upside for Investors - directorstalkinterviews.com
Ardent Health (ARDT) Falls 4.24% to $11.06, Approaches Key $10.51 SupportFibonacci Fan - dars.gov.et
RBC Capital raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com Australia
RBC Capital raises Ardent Health stock price target on EBITDA beat - Investing.com India
Ardent Moves on From Managers, Bumps Cost-Cutting Plan to $70M+ - HCI Innovation Group
RBC Adjusts PT on Ardent Health Partners to $13 From $12, Maintains Outperform Rating - marketscreener.com
Ardent Health, Inc. Announces Q2 2026 Earnings with Decline in Net Income - Kalkine Media
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
ARDT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
ARDT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Ardent Health (NYSE:ARDT) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Is Ardent Health (ARDT) Cheap On Lowered Guidance And Weaker Q2 Earnings? - Yahoo Finance
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13 - Moomoo
New Strong Sell Stocks for August 7th - The Globe and Mail
Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Guggenheim raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com India
Ardent Health (NYSE:ARDT) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Guggenheim raises Ardent Health stock price target on EBITDA beat - Investing.com
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $9 to $14 - Moomoo
Truist Adjusts Price Target on Ardent Health Partners to $13 From $12, Maintains Buy Rating - Moomoo
Ardent Health Inc (ARDT) (Q2 2026) Earnings Call Highlights: Raising Impact Program Savings ... - Yahoo Finance UK
Ardent Health Q2 Earnings Call Highlights - TradingView
Earnings call transcript: Ardent Health Q2 2026 EPS misses as stock rises 8% - Investing.com Canada
ARDT: Q2 results beat expectations with strong cost controls and reaffirmed 2026 guidance - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc - The National Law Review
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):